Ineffective control of Epstein-Barr-virus-induced autoimmunity increases the risk for multiple sclerosisHannes Vietzen, Elisabeth Puchhammer‐Stöckl, S. Berger et al.|Cell|2023Cited by 170
Early identification of individuals at risk for multiple sclerosis by quantification of EBNA-1381-452-specific antibody titersHannes Vietzen, Elisabeth Puchhammer-Stöckl, Christof Jungbauer et al.|Nature Communications|2025Cited by 16
Accumulation of Epstein-Barr virus–induced cross-reactive immune responses is associated with multiple sclerosisHannes Vietzen, Elisabeth Puchhammer‐Stöckl, Laura M. Kühner et al.|Journal of Clinical Investigation|2024Cited by 15
Ineffective control of Epstein–Barr virus infection is seen in MS: What is next?Paulus Rommer, Hannes Vietzen, Elisabeth Puchhammer‐Stöckl et al.|Clinical and Translational Medicine|2024Cited by 4
Association Between NK Cell Genetic Variants and the Development of Long COVID Associated‐ and Prepandemic Small Fiber NeuropathyMarianne Graninger, Elisabeth Puchhammer‐Stöckl, Verena Endmayr et al.|Journal of Medical Virology|2024Cited by 1